Acorn Capital Advisors as of March 31, 2026
Portfolio Holdings for Acorn Capital Advisors
Acorn Capital Advisors holds 22 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Terns Pharmaceuticals (TERN) | 26.2 | $92M | 1.7M | 52.72 | |
| Cg Oncology (CGON) | 21.8 | $77M | 1.1M | 67.74 | |
| Urogen Pharma (URGN) | 8.6 | $30M | 1.7M | 17.98 | |
| Puma Biotechnology (PBYI) | 7.5 | $26M | 4.1M | 6.39 | |
| Trevi Therapeutics (TRVI) | 7.3 | $26M | 2.1M | 11.93 | |
| Candel Therapeutics (CADL) | 4.9 | $17M | 3.5M | 4.92 | |
| Bicara Therapeutics (BCAX) | 3.6 | $13M | 643k | 19.89 | |
| Onkure Therapeutics Class A Com (OKUR) | 3.3 | $12M | 2.8M | 4.14 | |
| Jade Biosceinces Com New (JBIO) | 3.1 | $11M | 787k | 14.05 | |
| Protara Therapeutics Com Stk (TARA) | 2.6 | $9.1M | 1.8M | 5.21 | |
| Verastem (VSTM) | 2.2 | $7.8M | 1.5M | 5.30 | |
| Helus Pharma Com Stk (HELP) | 2.1 | $7.4M | 1.5M | 4.80 | |
| Leonabio Common Stock (LONA) | 1.9 | $6.5M | 635k | 10.28 | |
| Aura Biosciences (AURA) | 1.1 | $4.0M | 596k | 6.69 | |
| Aadi Bioscience (WHWK) | 1.1 | $3.9M | 1.1M | 3.45 | |
| Cardiff Oncology (CRDF) | 0.8 | $2.9M | 1.8M | 1.62 | |
| Q32 Bio (QTTB) | 0.6 | $2.0M | 315k | 6.42 | |
| Karyopharm Therapeutics Common Stock (KPTI) | 0.5 | $1.6M | 288k | 5.57 | |
| Jasper Therapeuritc (JSPR) | 0.4 | $1.2M | 1.4M | 0.88 | |
| X4 Pharmaceuticals | 0.3 | $967k | 234k | 4.13 | |
| Bioatla | 0.2 | $865k | 5.4M | 0.16 | |
| Vyne Therapeutics (VYNE) | 0.0 | $855.000000 | 1.4k | 0.60 |
